| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.23 | 5e-07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |